Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > What's Going on in US Premarket?
View:
Post by archeo753 on Sep 26, 2022 7:01am

What's Going on in US Premarket?

Low volume but still?  Up $.20.

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
THTX - Q 0.2 2.20 · 2.35 0.8 2.14     3.8 8 13      4.46  1.89 06:41:10 Sep 19 15 min RT 2¢

 

Recent Trades - Last 10 of 13
Time ET Ex Price Change Volume
06:41:10 Q 2.34 0.20 9
06:34:57 Q 2.34 0.20 25
06:29:20 Q 2.34 0.20 472
06:20:28 Q 2.34 0.20 200
06:17:03 Q 2.34 0.20 234
06:16:46 Q 2.34 0.20 75
06:16:46 Q 2.34 0.20 19
06:05:33 Q 2.34 0.20 34
06:05:33 Q 2.34 0.20 1
06:04:45 Q 2.38 0.24 17
Q:THTX - THERATECHNOLOGIES INC - https://theratech.com
Comment by muslix1 on Sep 26, 2022 7:42am
Theratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update it is not whit this news THTX move... 7081 shares at 2.33 $us...
Comment by SPCEO1 on Sep 26, 2022 8:14am
Seems like the Q3 announcement was issued a few days earlier than normal. Did they want to get that perfunctory PR out before issuing more significant news ahead of Wednesday's Cantor conference? If THTX has good cancer news to share it makes a lot of sense to share it in front of the audience of US cancer analysts at that conference.
Comment by LouisW on Sep 26, 2022 8:46am
If so, the PR would be released prior to the meeting.
Comment by SPCEO1 on Sep 26, 2022 9:37am
It turns out  it was a false alarm re: upcoming good news on TH-1902. A news service that tracks upcoming FDA decisions included the IV Push approval in its report this morning that came out at 7AM, likely triggering computer algo programs that track such developments to buy the stock in the pre-market. The buying start soon after that news item was posted. While IV Push will be nice to have, ...more  
Comment by qwerty22 on Sep 26, 2022 10:33am
At least it gives the appearance of some life in the stock.
Comment by Biobob on Sep 26, 2022 10:37am
More speculation about nothing.  It's starting to look like a sport hotline with long discussions about everything and nothing.  Cramer once said.. They know nothing.... sounds like that to me...
Comment by palinc2000 on Sep 26, 2022 9:01am
I dont have access to the old Corporate Presentation but I really like the New Presentation....  Sentiment can turn on a dime ... I really get the impression that this time "Firing on all cylinders" is an accurate representation of what is happening.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities